SGH
MRK icon

Sivik Global Healthcare’s Merck MRK Stock Holding History

Sivik Global Healthcare’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.81M Hold
40,000
– – 3.65% 5
2026
Q1 		$4.81M Buy
40,000
+10,000
+33% +$1.15M 3.65% 5
2025
Q4 		$3.16M Buy
+30,000
New +$2.82M 0.92% 39
2024
Q3 		– Sell
-65,874
Closed -$8.15M – 42
2024
Q2 		$8.15M Buy
+65,874
New +$8.49M 2.93% 8
2023
Q3 		– Sell
-50,000
Closed -$5.77M – 43
2023
Q2 		$5.77M Sell
50,000
-25,000
-33% -$2.84M 1.35% 25
2023
Q1 		$7.98M Buy
+75,000
New +$8.1M 3.43% 6
2021
Q4 		– Sell
-100,000
Closed -$7.51M – 52
2021
Q3 		$7.51M Buy
100,000
+40,000
+67% +$3.04M 1.79% 21
2021
Q2 		$4.67M Buy
+60,000
New +$4.46M 0.91% 31
2020
Q4 		– Sell
-62,880
Closed -$4.98M – 43
2020
Q3 		$4.98M Sell
62,880
-26,200
-29% -$2.05M 2.14% 26
2020
Q2 		$5.26M Buy
89,080
+5,240
+6% +$394K 1.74% 25
2020
Q1 		$5.12M Buy
83,840
+5,240
+7% +$412K 2.02% 22
2019
Q4 		$6.82M Sell
78,600
-10,480
-12% -$861K 2.53% 16
2019
Q3 		$7.16M Buy
89,080
+15,720
+21% +$1.26M 3.61% 5
2019
Q2 		$5.87M Sell
73,360
-26,200
-26% -$2.01M 1.42% 14
2019
Q1 		$7.9M Hold
99,560
– – 2.91% 8
2018
Q4 		$7.26M Sell
99,560
-26,200
-21% -$1.85M 3.91% 5
2018
Q3 		$8.51M Buy
125,760
+14,424
+13% +$919K 3.04% 5
2018
Q2 		$6.45M Buy
+111,336
New +$6.28M 2.48% 13
2017
Q3 		– Sell
-78,600
Closed -$4.77M – 83
2017
Q2 		$4.81M Hold
78,600
– – 1.76% 25
2017
Q1 		$4.77M Sell
78,600
-41,920
-35% -$2.54M 2.22% 18
2016
Q4 		$6.77M Sell
120,520
-5,240
-4% -$307K 3.23% 11
2016
Q3 		$7.49M Buy
125,760
+31,440
+33% +$1.84M 3.78% 6
2016
Q2 		$5.18M Buy
+94,320
New +$5.02M 2.58% 11

Other funds holding MRK

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Sivik Global Healthcare's MRK Position: Q2 2026 in Review

Sivik Global Healthcare held its Merck (MRK) position steady in Q2 2026 at 40,000 shares worth $4.81M. The position accounts for 3.65% of the portfolio, ranked #5.

Sivik Global Healthcare first reported a position in MRK in Q2 2016 and has held it in 23 quarters since. The position peaked at $8.51M in Q3 2018. 1,363 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Sivik Global Healthcare held 40,000 shares of Merck worth $4.81M as of Q2 2026.
  • Sivik Global Healthcare left its Merck share count unchanged in Q2 2026.
  • Merck made up 3.65% of Sivik Global Healthcare's portfolio in Q2 2026, its #5 holding.
  • Sivik Global Healthcare first reported a position in Merck in Q2 2016 and has held it in 23 quarters since.
  • Sivik Global Healthcare's Merck position peaked at $8.51M in Q3 2018.
  • 1,363 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Sivik Global Healthcare's 13F filing for Q2 2026, filed 20 Jul 2026.